Synthesis, characterization and biological activity of some unsymmetrical Schiff base transition metal complexes. 2016

Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
a Department of Chemistry , Yarmouk University , Irbid , Jordan .

In this study, several unsymmetrical Schiff bases and their cobalt and manganese complexes have been synthesized and characterized. The unsymmetrical Schiff bases were prepared from reaction of o-phenylendiamine derivatives with 1-hydroxy-2-acetonaphthone and then the product was reacted with the following aldehydes: salicyaldehyde, 2-hydroxynaphthaldehyde, 2-pyridinecarboxaldehyde and 2-qinolinecarboxaldehyde to produce the desired tetradentate unsymmetrical Schiff base ligands H2SL, H2NL, HPYL and HQN, respectively. Reaction of these ligands with cobalt and manganese salts produced complexes of the general formula [M(SL)], [(NL)], [M(PYL)] and [M(QL)]. All the complexes were characterized by elemental analysis, infrared spectroscopy, UV-visible spectroscopy, electrical conductivity and magnetic susceptibility measurements. The prepared complexes were examined for their anti-bacterial activity using gram-positive and gram-negative pathogens. The following complexes showed strong antibacterial activity against Staphylococcus aureus: MnSL1, MnSL2 and MnSL3. The genotoxic activity of four complexes, which are MnNL1, MnSL1, CoNL1 and CoSL1, were examined using 8-hydroxy-2-deoxy guanosine (8-OHdG) assay in cultured human blood lymphocytes. All examined complexes were found to be genotoxic at examined concentrations (0.1-100 µg/mL), but with variable magnitudes (p < 0.05). The levels of 8-OHdG induced by MnNL1 and MnSL1 were significantly higher than that induced by CoNL1 and CoSL1 ones. In general, the order of mutagenicity of the compounds is MnSL1 > MnNL1 > CoSL1 > CoNL1. In conclusion, some of the prepared complexes showed some biological activities that might be of interest for future research.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008345 Manganese A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D010655 Phenylenediamines Aniline compounds that contain two amino groups. They are used as a precursor in the synthesis of HETEROCYCLIC COMPOUNDS and POLYMERS. p-Phenylenediamine is used in the manufacture of HAIR DYES and is an ALLERGEN.
D003035 Cobalt A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis. Cobalt-59,Cobalt 59
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
January 2004, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
March 2013, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
August 2014, Bioorganic & medicinal chemistry letters,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
March 2010, Indian journal of pharmaceutical sciences,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
September 2007, Mycobiology,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
April 2004, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
May 2006, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
February 2024, ACS omega,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
July 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Fatima T Esmadi, and Omar F Khabour, and Khamis Abbas, and Abdel Elah Mohammad, and Ra'ad T Obeidat, and Doa'a Mfady
January 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Copied contents to your clipboard!